Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Grass pollen immunotherapy trial in adults with seasonal allergic rhinitis
2010-023536-16Phase 2Completed
- Sponsor
- Immune Tolerance Network
- Start
- Dec 2010
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of phleum pratense allergen extract and alutard-sq in seasonal allergic rhinitis (SAR) and allergic rhinoconjunctivitis (ARC) (3 arms), sponsored by Immune Tolerance Network. Started Dec 2010; status: completed.
02
Drugs
phleum pratense allergen extractalutard-sq
03
Conditions
seasonal allergic rhinitis (SAR)allergic rhinoconjunctivitis (ARC)
Beyond the preview
Go deeper on 2010-023536-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023536-16.